Reuters — Aurora Cannabis on Monday missed Wall Street expectations for fourth-quarter revenue as pandemic-related restrictions weighed down consumer demand, leading Canadian provinces to cut orders.
U.S.-listed shares of the company, which also posted a bigger-than-expected quarterly loss, were down two per cent in extended trading.
After more than three years into Canada’s legalization of recreational cannabis, profits have been wearing thin at most pot firms, weighed down by fewer-than-expected retail stores, cheaper rates on the black market and sluggish overseas growth.
Read Also
Trump says he’ll up Canadian tariff rate to 35 per cent next month
U.S. President Donald Trump ramped up his tariff assault on Canada on Thursday, saying the U.S. would impose a 35 per cent tariff on imports next month. Exceptions for goods under CUSMA, which includes many agricultural products, are expected to continue a White House official said.
Aurora last week said it would shut down a facility in Edmonton, without disclosing the number of employees that would be impacted by the move.
The company laid off hundreds of employees last year to mitigate the impact of the pandemic, shut facilities and amended its loan agreements.
Net revenue at its consumer cannabis business, its second largest segment, slumped 45 per cent to $19.5 million in the fourth quarter.
The Edmonton-based company’s total net revenue fell 20 per cent to $54.8 million, below Refinitiv analysts’ expectations of $56.28 million.
Aurora sold 11,346 kg of cannabis in the quarter, compared with 16,748 kg a year earlier.
On an adjusted basis, the company lost 68 cents per share, compared with Wall Street expectations for a loss of 27 cents per share, according to data from Refinitiv.
— Reporting for Reuters by Rithika Krishna in Bangalore.
